Stocks
Larimar Therapeutics, Inc.LRMR
NASDAQHealthcareBiotechnology$2.35
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company focused on developing therapies for rare genetic disorders, with its lead candidate targeting Friedreich's ataxia. Investors monitor the company for its pipeline progress and upcoming clinical trial readouts in the neuromuscular space.
52W Range: $1.92-$6.42
Congressional Interest in Larimar Therapeutics, Inc. (LRMR)
No congressional trades have been disclosed for Larimar Therapeutics, Inc. (LRMR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading LRMR?
No congressional trades found for this stock.